Department of Neurology, School of Medicine College of Health Sciences, Addis Ababa University, PO Box 6396, Liberia Street, Lideta sub-city, Addis Ababa, Ethiopia.
BMC Oral Health. 2020 Sep 3;20(1):244. doi: 10.1186/s12903-020-01227-y.
Trigeminal neuralgia (TN) is considered one of the most painful illnesses known to medical practice. Little is known about TN in Ethiopia. Our study aimed to assess clinical characteristics, treatment, and associated factors of TN.
A cross-sectional study was conducted on a total of 61 patients with confirmed Trigeminal neuralgia visiting outpatient neurology clinics of two government teaching Hospitals and two private health facilities in Addis Ababa, Ethiopia between June 2019 and March 2020.
Our participants' age range between 21 and 78 years with mean ± SD age of 50.7 ± 14.2 years. Males accounted for 50.8%. Twenty-five (41%) reported a prior history of one or more tooth extraction on the painful side. In the majority (68.9%) of the patient's right side of the face was affected. The mandibular nerve was the commonly involved branch (47.5%). Fifty-five (90.2%) of patients fulfilled criteria for classical TN and 9.8% had symptomatic TN. The majority of the participants reported mixed types of pain such as burning, lancinating, and electric shock-like. Well defined trigger zone was identified in one-third (36%) of cases. Carbamazepine was the most commonly prescribed drug with a median dose of 600 mg (IQR: 400 - 1000 mg). Two-third of the patients reported prominent satisfaction. The mean (± SD) dose of carbamazepine used to control the pain was significantly higher among those with dental extraction history as compared to those with no history of dental extraction (736 ± 478.6 mg Vs 661.1 ± 360.4 mg, respectively, T = - 2.06, p = 0.04 95% CI:-213.41 to - 2.98). A statistically significant number of patients who had single branch involvement reported prominent satisfaction with their treatment as compared to those who had more than one branch involvement. (95% CI: 1.3-3.8: p = 0.006).
The majority of our patients had Classical TN in the mandibular nerve distribution on the right side of the face and well satisfied with carbamazepine only treatment. Furthermore, we observed a higher proportion of dental extraction among our patients, hinting at the scale of miss and delayed-diagnoses. Thus, we recommend conducting a well-designed prospective study to support our findings.
三叉神经痛(TN)被认为是医学实践中已知的最疼痛的疾病之一。在埃塞俄比亚,人们对 TN 的了解甚少。我们的研究旨在评估 TN 的临床特征、治疗方法和相关因素。
本横断面研究共纳入 2019 年 6 月至 2020 年 3 月期间在埃塞俄比亚亚的斯亚贝巴的两家政府教学医院和两家私立卫生机构的门诊神经科就诊的 61 例确诊为三叉神经痛的患者。
我们的参与者年龄在 21 岁至 78 岁之间,平均年龄为 50.7 ± 14.2 岁。男性占 50.8%。25 名(41%)报告在疼痛侧有过一次或多次拔牙史。大多数(68.9%)患者的右侧面部受到影响。下颌神经是最常受累的分支(47.5%)。55 名(90.2%)患者符合经典 TN 的标准,9.8%为症状性 TN。大多数患者报告混合类型的疼痛,如烧灼感、刺痛和电击样。三分之一(36%)的患者有明确的触发区。卡马西平是最常用的药物,中位数剂量为 600mg(IQR:400-1000mg)。二分之一(66.7%)的患者报告治疗效果显著。与无拔牙史的患者相比,有拔牙史的患者用于控制疼痛的卡马西平平均剂量明显更高(分别为 736±478.6mg 与 661.1±360.4mg,T=-2.06,p=0.04,95%CI:-213.41 至-2.98)。与多支受累的患者相比,单支受累的患者报告治疗效果显著的比例更高(95%CI:1.3-3.8:p=0.006)。
我们的大多数患者右侧面部下颌神经分布处存在典型的三叉神经痛,且仅用卡马西平治疗就非常满意。此外,我们观察到我们的患者中有更高比例的拔牙,这表明存在漏诊和延迟诊断的情况。因此,我们建议进行一项精心设计的前瞻性研究来支持我们的发现。